For this purpose, we compared the PTEN expression in T cells from untreated MS patients and healthy donors in order to examine whether the observed hyperactivation of PKB/c-Akt is due to impaired PTEN expression and can therefore be associated with impaired immune regulation. The gene discussed is AKT1; the disease is myeloid sarcoma.